Tenet Healthcare Corporation (THC)
Official siteHEALTHCARE • MEDICAL CARE FACILITIES • NYSE
Market Cap: $23.20B
Last updated: Nov 17, 2026 at 4:31 PM ET
Tenet Healthcare Corporation (THC) Statistics
Tenet Healthcare (THC) has a market cap of $23.20B and an enterprise value of $33.77B. Its share count is down 8.89% from a year earlier. Its return on invested capital of 23.97% compares with a 14.52% median across 10 similar companies.
Total Valuation
Enterprise value is 45.55% above the market cap, as debt exceeds cash.
| Market Cap | $23.20B |
|---|---|
| Enterprise Value | $33.77B |
| Latest price (Nov 17, 2026) | $282.02 |
Key Dates
The next earnings report is expected on Feb 9, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 9, 2027 (expected) |
|---|---|
| Last Earnings Date | Oct 29, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 1.0x and 4.2x. Its year-end P/E ranged from 5.1x to 19.2x from 2016 to 2025.
| P/E Ratio | 12.7x |
|---|---|
| Forward P/E | 12.3x |
| P/S Ratio | 1.0x |
| Forward P/S | 1.0x |
| P/B Ratio | 4.2x |
| P/FCF Ratio | 6.8x |
| P/OCF Ratio | 5.5x |
| PEG Ratio | 3.0 |
Enterprise Valuation
Counting debt and cash, the company is valued at 5.1x EBITDA and 10.0x free cash flow.
| EV / Earnings | 8.9x |
|---|---|
| EV / Sales | 1.5x |
| EV / EBITDA | 5.1x |
| EV / EBIT | 6.1x |
| EV / FCF | 10.0x |
Price Statistics
The stock is up 46.20% over 52 weeks and trades 4.90% above its 50-day average.
| Beta (1Y) | 0.58 |
|---|---|
| 52-Week Change | +46.20% |
| 1-Month Change | +5.87% |
| 3-Month Change | +5.03% |
| 6-Month Change | +47.35% |
| 5-Year Change | +281.31% |
| 10-Year Change | +1286.35% |
| Total Return (1Y) | +46.20% |
| Total Return (3Y CAGR) | +64.15% |
| Total Return (5Y CAGR) | +29.12% |
| Return vs SPY (1Y) | +34.57% |
| Max Drawdown (1Y) | -34.08% |
| Max Drawdown (3Y) | -34.48% |
| Sharpe Ratio (1Y) | 0.90 |
| Correlation with SPY (1Y) | 0.19 |
| 50-Day Average | $268.84 |
| 200-Day Average | $225.81 |
| 52-Week Range | $157.58 to $301.44 |
| RSI (14 Days) | 53.5 |
| Average Volume (20 Days) | 919.26K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.58x current liabilities, and total debt is 2.43x shareholder equity.
| Current Ratio | 1.58x |
|---|---|
| Quick Ratio | 1.52x |
| Debt / Equity | 2.43x |
| Debt / EBITDA | 2.05x |
| Debt / FCF | 3.98x |
| Interest Coverage | 6.73x |
Returns and Efficiency
Return on invested capital is 23.97% over the last 12 months, against a 5-year average of 16.08%.
| Return on Equity (ROE) | 70.06% |
|---|---|
| Return on Assets (ROA) | 12.07% |
| Return on Invested Capital (ROIC) | 23.97% |
| Return on Capital Employed (ROCE) | 21.15% |
| ROE (5Y Average) | 93.26% |
| ROA (5Y Average) | 7.14% |
| ROIC (5Y Average) | 16.08% |
| Asset Turnover | 0.73x |
| Inventory Turnover | 25.96x |
| Receivables Turnover | 8.52x |
| Cash Conversion Cycle | 0 days |
Taxes
Income tax took 19.40% of pretax income over the last 12 months.
| Income Tax (TTM) | $918.00M |
|---|---|
| Effective Tax Rate | 19.40% |
Scores
THC has an Altman Z-Score of 2.32, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 2.32 |
|---|---|
| Altman Z Zone | Grey |
| Piotroski F-Score | 7 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $22.15B over the last 12 months is up 6.22% from the 12 months before.
| Revenue | $22.15B |
|---|---|
| Revenue Growth (YoY) | +6.22% |
| Gross Profit | $13.35B |
| Operating Income | $5.40B |
| Pretax Income | $4.73B |
| Net Income | $3.81B |
| EBITDA | $6.47B |
| EBIT | $5.56B |
| Reported EPS (TTM) | $22.28 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 17.22% of the $31.59B in total assets.
| Cash and Equivalents | $2.67B |
|---|---|
| Total Debt | $13.24B |
| Net Debt | $10.57B |
| Net Debt Per Share | $131.89 |
| Working Capital | $3.11B |
| Shareholder Equity | $5.44B |
| Book Value Per Share | $67.94 |
| Tangible Book Value | -$7.42B |
| Total Assets | $31.59B |
| Total Liabilities | $22.00B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $910.00M of capital spending, operating cash flow left $3.33B of free cash flow.
| Operating Cash Flow | $4.24B |
|---|---|
| Capital Expenditures | $910.00M |
| Free Cash Flow | $3.33B |
| FCF Per Share | $41.33 |
| Depreciation and Amortization | $913.00M |
| Share Repurchases | $1.81B |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 24.37%.
| Gross Margin | 60.28% |
|---|---|
| Operating Margin | 24.37% |
| Pretax Margin | 21.36% |
| Net Margin | 17.22% |
| EBITDA Margin | 29.21% |
| EBIT Margin | 25.09% |
| FCF Margin | 15.02% |
Growth
Revenue grew 3.24% a year over 3 years, and EPS 34.93% a year.
| Revenue Growth (3Y CAGR) | +3.24% |
|---|---|
| Revenue Growth (5Y CAGR) | +2.84% |
| EPS Growth (3Y CAGR) | +34.93% |
| EPS Growth (5Y CAGR) | +16.26% |
| FCF Growth (3Y CAGR) | +99.01% |
| FCF Growth (5Y CAGR) | -2.47% |
| Operating Income Growth (3Y CAGR) | +14.56% |
| Book Value Per Share Growth (2Y CAGR) | +76.34% |
Dividends and Yields
THC does not pay a dividend. Its free cash flow yield is 14.73%.
| Earnings Yield | 7.87% |
|---|---|
| FCF Yield | 14.73% |
| Buyback Yield | 8.02% |
| Shareholder Yield | 14.33% |
Stock Splits
The last split was a 1-for-4 reverse split on Oct 11, 2012.
| Last Split Date | Oct 11, 2012 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:4 |
Peer Position
Against 12 similar companies, THC has the 8th highest P/E and the 9th highest P/S.
P/E RatioPeer median 18.8x
P/S RatioPeer median 1.4x
ROICPeer median 14.52%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +7.19%
| P/E Ratio | 12.7x vs 18.8x median |
|---|---|
| P/S Ratio | 1.0x vs 1.4x median |
| ROIC | 23.97% vs 14.52% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +6.22% vs +7.19% median |
Analyst Forecast
Consensus estimates put revenue growth at 2.77% and EPS growth at 10.04% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +2.77% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +10.04% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About THC
What is THC's market cap?
Tenet Healthcare has a market cap of $23.20B. Its enterprise value, which adds debt and subtracts cash, is $33.77B.
What is THC's P/E ratio?
Tenet Healthcare has a trailing P/E ratio of 12.7x and a forward P/E of 12.3x.
How many shares of THC are outstanding?
Tenet Healthcare has 80.13M shares outstanding. The count is down 8.89% from a year earlier.
Does THC pay a dividend?
No. Tenet Healthcare does not pay a dividend.
How much debt does THC have?
Tenet Healthcare has $13.24B of total debt and $2.67B of cash and equivalents, a net debt position of $10.57B.
THC pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts